Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (5889)	3/13/1998 9:14:00 AM
From: RT	Read Replies (1) \| Respond to of 23519

<<Also, March 15th almost here. There's still a 10+ mill short position. New plant approval almost here. It's going to be interesting>> Blankmind, Everyone including the 10M short positions realizes that the new plant will be approved within the next two weeks. If it doesn't then we may go lower. If it does, I wouldn't be surprised if the stock rebounds less than 3 points ($15 range). FDA approval may give us another 3 points ($18 range) Dismisal of class action lawsuit, add 3, were looking at ($21-22 range). Beyond that, sales and profit will dictate price. We already know 1Q will be a disappointment, so chill out. RT